Collaborating On Common Challenges
The Think Tank on Advancing Precision Medicine in Rare Cancers is a highly interactive meeting that brings together clinicians, researchers, industry representatives, advocates, and patients to collaborate on common challenges in rare cancer research and treatment.
Leveraging the successful Think Tank model established through over a decade of TargetCancer Foundation meetings, it creates a collaborative environment where diverse perspectives and ideas thrive. This meeting also builds on the progress made through TargetCancer Foundation’s TCF-001 TRACK study, a nationwide, decentralized, patient-driven clinical trial studying precision medicine in rare cancers.
SAVE THE DATE!
The 2025 Think Tank on Advancing Precision Medicine in Rare Cancers will be held on October 29, 2025, in Boston, MA.
Please check back for more details this spring.
On November 20, 2024, the 3rd Think Tank on Advancing Precision Medicine in Rare Cancers was held in Boston, MA, uniting key stakeholders across rare cancers for a day of interactive discussions on issues related to rare cancer treatment development and access. The day began and ended with rare cancer patient and caregiver perspectives, and also focused on topics such as rare cancer clinical trials, tissue agnostic therapies, functional precision medicine, and genetic testing. You can view the full agenda and videos from the Think Tank at the links below.
2024 Steering Committee
Jennifer Levin Carter, MD, MPH, MBA
Medzown, Inc.
A. John Iafrate, MD, PhD
Massachusetts General Hospital
Harvard Medical School
Razelle Kurzrock, MD
Froedtert and Medical College
of Wisconsin
Thank You To Our Sponsors
What participants are saying
This was a fantastic #RareCancer #PrecisionMedicine meeting @targetcancer in Boston! So much enthusiasm from patients and patient advocates to move the field forward.
Vivek Subbiah, MD
Sarah Cannon Research Institute
Originally posted on Twitter
This is genuinely the best rare cancer meeting I have ever attended.
Razelle Kurzrock, MD
Froedtert and Medical College of Wisconsin
…thank you for allowing me to be a part of the discussion of challenges, goals, opportunities and best practices in addressing the needs of patients facing rare cancers. What a wonderful group of humans you gathered. I was so inspired.
Katie Ortman Doble
Patient Keynote Speaker,
2023 Think Tank on Advancing Precision Medicine in Rare Cancers
View and download materials from past meetings
TCF-001 TRACK Live Molecular Tumor Board 2023: Osteosarcoma
We are grateful to our industry partners for supporting these meetings and for their dedication to developing treatments for patients with rare cancers.
Join our Mailing List
TargetCancer Foundation
TargetCancer Foundation is a recognized 501(c)(3) charity, Tax ID 26-4510094.
All content and images copyright © 2025 TargetCancer Foundation. All rights reserved. | Privacy Policy